Is MDT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MDT. It does not provide personalized investment advice.

MDT (Medtronic) Stock Analysis - Financials

Medtronic (MDT) is a publicly traded Healthcare sector company. As of October 3, 2026, MDT trades at $86.91 with a market cap of $110.57B and a P/E ratio of 28.07. MDT moved -0.07% today. Year to date, MDT is -10.07%; over the trailing twelve months it is -9.53%. Its 52-week range spans $73.31 to $106.33. Analyst consensus is buy with an average price target of $103.41. Rallies surfaces MDT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are MDT's key financials?

MDT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MDT recently traded at $86.91. Market cap is $110.57B. P/E ratio is 28.07. Revenue is $17.52B.

MDT Key Metrics

Key financial metrics for MDT
Metric	Value
Price	$86.91
Market Cap	$110.57B
P/E Ratio	28.07
EPS	$3.16
Dividend Yield	0.72%
52-Week High	$106.33
52-Week Low	$73.31
Volume	29.91M
Avg Volume	0
Revenue (TTM)	$17.52B
Net Income	$3.12B
Gross Margin	74.06%

MDT Analyst Consensus

20 analysts cover MDT: 0 strong buy, 12 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $103.41.

Common questions about MDT

What are MDT's key financials?: MDT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MDT recently traded at $86.91. Market cap is $110.57B. P/E ratio is 28.07. Revenue is $17.52B.
Is MDT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MDT. It does not provide personalized investment advice.